Program: Fourth Annual Primary Care MASLD/MASH Summit 2025

Thursday, December 4, 2025
6:00 PM - 6:05 PM																Welcome & Opening Remarks Michael Betel, Fatty Liver Alliance Mark Swain, University of Calgary
6:05 PM - 6:30 PM																Understanding MASLD and MASH and the relationship between Primary Care and Hepatologist MASLD & MASH simplified: clear, practical definitions Screening criteria and risk factors Brief review of updated guidelines and nomenclature Mazen Noureddin, Houston Research Institute
6:30 PM - 7:00 PM																Primary Care Toolbox: Managing Fatty Liver in Daily Practice What labs to order How to integrate liver health into patients visits Importance of NITs: FIB-4, FibroScan, ultrasound, ELF, and non-invasive scores. When and how to use them Workflow tips – Optimizing efficiency and improving care Naim Alkhouri, Naim Alkhouri INC James Kim, University of Calgary
7:00 PM - 7:25 PM																The Patient Voice: Obesity and Liver Disease Why the patient’s voice is so important? Barriers to care (stigma, confusion, fear) What finally worked—and why How Primary Care made (or could have made) a difference Kerry Sivia, Fatty Liver Alliance Gina Madison, Liver Education Advocates
7:25 PM - 7:55 PM																Lifestyle Rx: Pearls for a busy Primary Care Practice Addressing real world nutritional advice – Practical strategies for Primary Care Addressing patient challenges and stigma Brief and Practical lifestyle intervention strategies for busy clinics Melina Manolas, Weill Cornell Medicine Jonathan Stine, Penn State Health Milton S. Hershey Medical Center
7:55 PM - 8:25 PM																Integrating Available Medications in Primary Care for management of Fatty Liver disease Role of GLP-1s, statins, insulin sensitizers, and upcoming MASH therapies Considerations for T2D, obesity, CKD, and polypharmacy What’s in the pipeline Diabetes Canada Guidelines / CanMASLD Guidelines? James Kim, University of Calgary Alnoor Ramji, University Of British Columbia
8:25 PM - 8:55 PM																Case-Based Panel: What Would You Do? Newly diagnosed patient with elevated ALT & diabetes Patient with advanced fibrosis on FibroScan but no symptoms Young patient with obesity and normal liver enzymes Melina Manolas, Weill Cornell Medicine Lisa Schaffer, Obesity Canada Rick Ward, University of Calgary
8:55 PM - 9:00 PM																Closing Remarks: Primary Care as Liver Health Leaders Michael Betel, Fatty Liver Alliance